Onset of multiple sclerosis associated with anti-TNF therapy.

Authors
Category Primary study
JournalNeurology
Year 2001
Therapies aimed at inhibiting tumor necrosis factor (TNF), a proinflammatory cytokine implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report a patient with new onset MS closely associated with the initiation of anti-TNF therapy for juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this individual.
Epistemonikos ID: 1d8a3fe44ed98154bc378ea7a94b1333f81fad85
First added on: Dec 16, 2023